1
3
®
column CHIRALCEL
IC column (250AC
x
CE4.6PT
m
E
m
D
); MA52
N
0.
U
11
S
97
C
,
R
fou
I
n
P
d
T
: 520.1199; MS (ESI+): m/z 520.12 (100,
+
nhexane/iPrOH 97:3, 1.0 mL/min, 25 °C): tR1 = 19.07 min and t
[M+H] )
R2
=
26.06 min (ee: 81% with procedure A and 86% with procedure
2
®
Diethyl
3-benzyl-9-(tert-butyl)-3-vinyl-2,3-dihydrobenzo[e]
B); Chiral HPLC 15aa : analytical column CHIRALCEL IC
column (250 x 4.6 mm); nhexane/iPrOH 97:3, 1.0 mL/min, 25
pyrrolo[1,2-c][1,2,3]oxathiazine-1,1(10bH)-dicarboxylate 5,5-
dioxide (15ad)
°
C): tR1 = 24.49 min and tR2 = 30.82 min (ee: 78% with
1
The title compound was prepared according to the representative
procedure A from the corresponding vinylcyclopropane 14a (32
mg, 0.13 mmol) and cyclic N-sulfonyl imine 4d (38 mg, 0.16
mmol) to give colorless oil (66.9 mg, 95%). dr: 1:1 (determined
procedure A and 30% with procedure B); [α] 15aa = +38.7 (c
D
2
0
.62, CHCl , 81% ee); [α] 15aa = +15.5 (c 1.55, CHCl , 78%
3
D
3
ee)
1
Diethyl
3-benzyl-8-bromo-3-vinyl-2,3-dihydrobenzo[e]pyrrolo
by H NMR of the crude product); Rf = 0.50 (eluent:
1
[
1,2-c][1,2,3]oxathiazine-1,1(10bH)-dicarboxylate 5,5-dioxide
Pentane/Et O 8:2, UV and KMNO staining); H NMR (400
2
4
(15ab)
MHz, CDCl ): δ 7.46 (m, 1H), 7.36-7.22 (m, 13H), 6.95 (d, J =
3
The title compound was prepared according to the representative
Procedure A from the corresponding vinylcyclopropane 14a (32
mg, 0.13 mmol) and cyclic N-sulfonyl imine 4b (42 mg, 0.16
mmol) to give colorless oil (48.4 mg, 66%). dr: 1:1 (determined
8.8 Hz, 1H), 6.93 (d, J = 8.8 Hz, 1H), 6.50 (dd, J = 17.5 and 11.1
Hz, 1H), 6.18 (dd, J = 17.4 and 10.8 Hz, 1H), 5.48 (s, 1H), 5.43
(s, 1H), 5.36 (d, J = 10.9 Hz, 1H), 5.21 (d, J = 11.1 Hz, 1H), 5.16
(d, J = 17.5 Hz, 1H), 5.09 (d, J = 17.3 Hz, 1H), 4.38-4.17 (m,
4H), 3.89-3.65 (m, 4H), 3.54 (d, J = 13.5 Hz, 1H), 3.44 (d, J =
13.6 Hz, 1H), 3.39 (d, J = 13.8 Hz, 1H), 3.21 (d, J = 13.8 Hz,
1H), 2.92 (d, J = 14.2 Hz, 1H), 2.86 (d, J = 14.1 Hz, 1H), 2.71 (d,
J = 14.1 Hz, 1H), 2.55 (d, J = 14.1 Hz, 1H), 1.31 (dt, J = 13.4
and 7.2 Hz, 6H), 1.26 (s, 9H), 1.23(s, 9H), 0.90 (t, J = 7.2 Hz,
1
by H NMR of the crude product); Rf = 0.40 (eluent:
1
pentane/Et O 8:2, UV and KMNO staining); H NMR (400
2
4
MHz, CDCl ): δ 7.35-7.19 (m, 15H), 7.11-7.09 (m, 1H), 6.47
3
(
1
dd, J = 17.5 and 11.1 Hz, 1H), 6.17 (dd, J = 17.2 and 10.9 Hz,
H), 5.42 (s, 1H), 5.37 (d, J = 11.0 Hz, 1H), 5.33 (s, 1H), 5.23 (d,
J = 11.1 Hz, 1H), 5.16 (d, J = 17.5 Hz, 1H), 5.07 (d, J = 17.3 Hz,
13
3H), 0.75 (t, J = 7.2 Hz, 3H) ppm; C NMR (100 MHz, CDCl ):
3
1
1
H), 4.38-4.22 (m, 4H), 3.95-3.75 (m, 4H), 3.57 (d, J = 13.5 Hz,
H), 3.41 (d, J = 13.6 Hz, 1H), 3.38 (d, J = 14.0 Hz, 1H), 3.20 (d,
δ 169.9, 169.5, 168.9, 168.3, 148.4, 148.0, 148.0, 147.9, 140.4,
137.4, 136.1, 135.4, 131.3 (2C), 131.0 (2C), 128.3 (2C), 128.0
(2C), 127.1, 126.8, 126.3, 126.2, 124.3, 123.8, 119.9, 119.6,
117.9, 117.6, 117.6, 117.6, 114.7, 114.7, 71.8, 71.0, 67.2, 66.0,
62.9, 62.7, 61.9, 61.8, 44.4, 44.2, 42.6, 40.0, 34.6, 34.5, 31.2
J = 13.8 Hz, 1H), 2.91-2.86 (m, 2H), 2.72 (d, J = 14.0 Hz, 1H),
.48 (d, J = 14.1 Hz, 1H), 1.29 (dt, J = 9.1 and 7.2 Hz, 6H), 0.99
2
13
(
t, J = 7.2 Hz, 3H), 0.89 (t, J = 7.2 Hz, 3H) ppm; C NMR (100
MHz, CDCl ): δ 169.8, 169.1, 168.5, 167.9, 151.1, 150.6, 139.9,
-
1
(3C), 31.2 (3C), 14.0, 14.0, 13.4, 13.3 ppm; FTIR neat (cm ):
2965, 1731, 1496, 1384, 1368, 1261, 1179, 1121, 1099, 1060,
860, 730, 705; HRMS-TOF (+) calculated for C H NO S (m/z):
3
1
1
1
6
1
1
37.3, 136.0, 135.2, 131.3 (2C), 131.0 (2C), 130.2, 130.0, 128.8,
28.4 (2C), 128.2, 128.2, 128.1, 128.1 (2C), 122.3, 122.1, 121.9,
21.5, 119.9, 119.5, 117.8, 115.0, 72.1, 71.2, 66.8, 65.6, 62.8,
2.8, 62.6, 62.2, 62.1, 61.7, 44.5, 44.2, 42.4, 39.8, 14.0, 13.9,
2
9
36
7
+
[M+H] : calculated: 542.2212, found: 542.2213; MS (ESI+): m/z
+
542.22 (100, [M+H] )
-
1
3.5, 13.5 ppm; FTIR neat (cm ): 2983, 1730, 1604, 1482, 1388,
Diethyl
[1,2-c][1,2,3]oxathiazine-1,1(10bH)-dicarboxylate 5,5-dioxide
15ca)
3-benzyl-8-bromo-3-vinyl-2,3-dihydrobenzo[e]pyrrolo
261, 1195, 1177, 1096, 909, 861, 786, 755, 732, 703; HRMS-
+
TOF (+) calculated for C H NO SBr (m/z): [M+H] : calculated:
5
25
27
7
(
64.0692, found: 564.0690; MS (ESI+): m/z 564.07 (100,
+
The title compound was prepared according to the representative
procedure A or B from the corresponding vinylcyclopropane 14c
(29 mg, 0.13 mmol) and cyclic N-sulfonyl imine 4a (29 mg, 0.16
mmol) to give white solid (A: 49 mg, 92%; B: 48 mg, 90%). m.p.:
[
M+H] )
Diethyl
3-benzyl-7-chloro-3-vinyl-2,3-dihydrobenzo[e]pyrrolo
[
1,2-c][1,2,3]oxathiazine-1,1(10bH)-dicarboxylate 5,5-dioxide
1
(15ac)
76.5-85.7 °C; dr: 1:1 (determined by H NMR of the crude
The title compound was prepared according to the representative
procedure A or B from the corresponding vinylcyclopropane 14a
product); Rf = 0.30 (eluent: pentane/Et O 8:2, UV and KMNO
2
4
1
staining); H NMR (400 MHz, CDCl ): δ 7.40 (dt, J = 7.9 and 1.2
3
(
32 mg, 0.13 mmol) and cyclic N-sulfonyl imine 4c (34 mg, 0.16
Hz, 1H), 7.36 (dt, J = 7.9 and 1.2 Hz, 1H), 7.32-7.27 (m, 2H),
7.17-7.11 (m, 2H), 7.01 (d, J = 1.2 Hz, 1H), 6.99 (d, J = 1.2 Hz,
1H), 6.30 (dd, J = 17.5 and 10.8 Hz, 1H), 6.05 (dd, J = 17.2 and
10.7 Hz, 1H), 5.74 (s, 1H), 5.69 (s, 1H), 5.34-5.18 (m, 4H), 4.41-
4.28 (m, 4H), 4.00-3.86 (m, 4H), 2.83 (d, J = 13.8 Hz, 1H), 2.74
(d, J = 13.6 Hz, 1H), 2.68 (d, J = 13.6 Hz, 1H), 2.43 (d, J = 13.6
Hz, 1H), 1.76 (s, 3H), 1.68 (s, 3H), 1.34 (td, J = 7.2 and 4.8 Hz,
mmol) to give colorless oil (A: 60 mg, 89%; B: 46 mg, 68%). dr:
1
1
:1 (determined by H NMR of the crude product); Rf = 0.28
1
(eluent: pentane/Et O 8:2, UV and KMNO staining); H NMR
2
4
(400 MHz, CDCl ): δ 7.39-7.22 (m, 13H), 7.14-7.11 (m, 1H),
3
7
.36 (dt, J = 18.1 and 8.0 Hz, 2H), 6.49 (dd, J = 17.5 and 11.1
Hz, 1H), 6.18 (dd, J = 17.2 and 10.8 Hz, 1H), 5.51 (s, 1H), 5.40
1
3
(
(
s, 1H), 5.38 (d, J = 10.8 Hz, 1H), 5.24 (d, J = 11.0 Hz, 1H), 5.18
d, J = 17.5 Hz, 1H), 5.08 (d, J = 17.3 Hz, 1H), 4.39-4.22 (m,
6H), 0.97 (t, J = 7.2 Hz, 3H), 0.92 (t, J = 7.2 Hz, 3H) ppm; C
NMR (100 MHz, CDCl ): δ 169.8, 169.6, 168.2, 167.9, 150.7,
3
4
1
1
1
H), 3.92-3.73 (m, 4H), 3.59 (d, J = 13.6 Hz, 1H), 3.42 (d, J =
3.6 Hz, 1H), 3.40 (d, J = 14.0 Hz, 1H), 3.21 (d, J = 13.8 Hz,
H), 2.93-2.88 (m, 2H), 2.73 (d, J = 14.1 Hz, 1H), 2.50 (d, J =
4.1 Hz, 1H), 1.29 (dt, J = 10.5 and 7.1 Hz, 6H), 0.96 (t, J = 7.2
150.4, 141.7, 140.0, 129.5, 129.5, 127.6, 127.4, 124.8, 124.8,
120.1, 120.0, 118.6, 118.5, 67.4, 66.3 (2C), 65.8, 62.7, 62.6, 62.3,
62.3, 62.2, 62.0, 47.7, 45.7, 24.9, 24.1, 14.0, 14.0, 13.5, 13.4
-
1
ppm; FTIR neat (cm ): 2989, 1723, 1455, 1390, 1374, 1267,
1186, 1164, 1039, 929, 892, 850, 818, 797, 766, 756, 721, 705;
13
Hz, 3H), 0.92 (t, J = 7.2 Hz, 3H) ppm; C NMR (100 MHz,
CDCl ): δ 169.8, 169.1, 168.5, 167.9, 146.9, 146.4, 139.9, 137.3,
+
HRMS-TOF (+) calculated for C H NO S (m/z): [M+H] :
3
19 24
7
1
1
1
6
1
1
36.0, 135.2, 131.3 (2C), 131.0 (2C), 130.2, 130.0, 128.4 (2C),
28.1 (2C), 127.2, 126.9, 125.7, 125.2, 125.1, 125.0, 123.7,
23.4, 122.8, 122.3, 117.8, 115.0, 72.2, 71.3, 67.1, 65.9, 62.8,
2.8, 62.8, 62.2, 62.0, 61.9, 44.5, 44.2, 42.7, 40.1, 14.0, 13.9,
calculated : 410.1273, found: 410.1275; MS (ESI+): m/z 410.13
(100, [M+H] )
+
Diethyl
3-isopropyl-3-vinyl-2,3-dihydrobenzo[e]pyrrolo[1,2-
-
1
3.4, 13.4 ppm; FTIR neat (cm ): 2983, 1730, 1447, 1390, 1264,
c][1,2,3]oxathiazine-1,1(10bH)-dicarboxylate 5,5-dioxide (15da)
The title compound was prepared according to the representative
procedure A from the corresponding vinylcyclopropane 14d (33
mg, 0.13 mmol) and cyclic N-sulfonyl imine 4a (29 mg, 0.16
196, 1178, 1147, 1072, 926, 854, 756, 731, 704; HRMS-TOF
+
(+) calculated for C H NO SCl (m/z): [M+H] : calculated:
25
27
7